Hepatectomy without portal triad clamping may decrease the incidence of liver injury; however, the effects of
hepatectomy without portal triad clamping in the treatment of
spontaneous rupture of
hepatocellular carcinoma (SRHCC) remain unclear. The aims of the present study were to evaluate the therapeutic value of
hepatectomy without portal triad clamping in the treatment of patients with SRHCC. The present study retrospectively reviewed patients with SRHCC who received
hepatectomy without portal triad clamping (non-clamping group) and the therapeutic efficacy was compared with that of 20 patients with SRHCC undergoing the same surgery in the presence of portal triad clamping (clamping group). Following
hepatectomy, the non-clamping group exhibited a significantly lower incidence of
acute liver failure compared with the clamping group (P<0.05). No significant differences in
operative time, intra-operative blood loss, disease-free or overall survival times between the two groups were identified (all P>0.05). At 1 week and 2 weeks after surgery, the non-clamping group exhibited significantly lower
alanine aminotransferase,
aspartate aminotransferase and total
bilirubin serum levels compared with the clamping group (all P<0.05).
Hepatectomy without portal triad clamping may decrease the incidence of liver injury and
liver failure in patients with SRHCC, suggesting that it may be a safe and effective therapeutic strategy.